Related Experiment Video
Updated: Oct 2, 2025

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
Association of C-reactive Protein with Cardiovascular Outcomes: A Mendelian Randomization Study in the Japanese
Ming Yang Cao1, Di Liu2, Xiao Yu Zhang3
1Beijing Key Laboratory of Clinical Epidemiology, School of Public Health, Capital Medical University, Beijing 100069, China.
Insights
C-reactive protein (CRP) shows no causal link to stroke, atrial fibrillation, or arrhythmia. Suggestive evidence links CRP to congestive heart failure, warranting further investigation into this cardiovascular disease risk.
Area of Science:
- Cardiovascular Epidemiology
- Genetic Epidemiology
- Biomarkers
Background:
- C-reactive protein (CRP) is linked to cardiovascular disease (CVD) risk in observational studies.
- The causal relationship between CRP and specific cardiovascular outcomes remains uncertain.
Purpose of the Study:
- To investigate the potential causal effect of C-reactive protein (CRP) on cardiovascular outcomes.
- To examine the causal association between genetically predicted CRP levels and ischemic stroke, atrial fibrillation, arrhythmia, and congestive heart failure.
Main Methods:
- Two-sample Mendelian randomization (MR) analysis using summary statistics from the Japanese Encyclopedia of Genetic association by Riken (JENGER).
- Four single-nucleotide polymorphisms (SNPs) associated with CRP levels were utilized as instrumental variables.
- Inverse-variance weighted (IVW), penalized weighted median, and weighted median methods were employed for MR estimation, with MR-Egger regression assessing pleiotropy.
Main Results:
- No significant causal association was detected between genetically determined CRP levels and ischemic stroke, atrial fibrillation, or arrhythmia across all MR methods.
- The IVW method suggested a potential causal link between CRP and congestive heart failure (OR: 1.337, P=0.046), though not consistently supported by other methods.
- No substantial evidence of pleiotropy or heterogeneity was observed in the analyses.
Conclusions:
- Mendelian randomization analysis provides suggestive evidence for a causal association between C-reactive protein and congestive heart failure.
- No causal relationship was established between CRP and ischemic stroke, atrial fibrillation, or arrhythmia.
- Further research is recommended to confirm the link between CRP and congestive heart failure.
Objective:
Traditional epidemiological studies have shown that C-reactive protein (CRP) is associated with the risk of cardiovascular diseases (CVDs). However, whether this association is causal remains unclear. Therefore, Mendelian randomization (MR) was used to explore the causal relationship of CRP with cardiovascular outcomes including ischemic stroke, atrial fibrillation, arrhythmia and congestive heart failure.
Methods:
We performed two-sample MR by using summary-level data obtained from Japanese Encyclopedia of Genetic association by Riken (JENGER), and we selected four single-nucleotide polymorphisms associated with CRP level as instrumental variables. MR estimates were calculated with the inverse-variance weighted (IVW), penalized weighted median and weighted median. MR-Egger regression was used to explore pleiotropy.
Results:
No significant causal association of genetically determined CRP level with ischemic stroke, atrial fibrillation or arrhythmia was found with all four MR methods (all Ps > 0.05). The IVW method indicated suggestive evidence of a causal association between CRP and congestive heart failure ( OR: 1.337, 95% CI: 1.005-1.780, P = 0.046), whereas the other three methods did not. No clear pleiotropy or heterogeneity were observed.
Conclusions:
Suggestive evidence was found only in analysis of congestive heart failure; therefore, further studies are necessary. Furthermore, no causal association was found between CRP and the other three cardiovascular outcomes.
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Coronary Artery Disease IV: Preventive Measures
Relative Risk
Bias in Epidemiological Studies
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...

